Местные гемостатические средства при реконструктивно-пластических операциях на матке: возможности и перспективы применения

1. Mikashima Y., Imamura H., Shirakawa Y., Takagi H., Okazaki K. Hypersensitive reaction of oxidized regenerated cellulose powder in total knee arthroplasty. Cureus. 2024; 16(4): e59097. https://dx.doi.org/10.7759/cureus.59097
2. Zhou H., Ge J., Bai Y., Liang C., Yang L. Translation of bone wax and its substitutes: history, clinical status and future directions. J. Orthop. Translat. 2019; 17: 64-72. https://dx.doi.org/10.1016/j.jot.2019.03.005
3. Sutton L. History of the hemostat. JAMA Dermatol. 2017; 153(9): 914. https://dx.doi.org/10.1001/jamadermatol.2017.2656
4. Baird E.O., McAnany S.J., Lu Y., Overley S.C., Qureshi S.A. Hemostatic agents in spine surgery: a critical analysis review. JBJS Rev. 2015; 3(1): e2. https://dx.doi.org/10.2106/JBJS.RVW.N.00027
5. Колесов С.В., Васильев А.Н., Шахин А.В., Рассовский С.В., Казьмин А.И., Швец В.В., Переверзев В.С., Баранов С.А., Абдулин Т.В., Багиров С.Б., Морозова Н.С., Бибикова Е.Е. Местные кровоостанавливающие препараты в хирургии позвоночника. Обзор литературы. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2025; 32(1): 293-304.
6. Tompeck A.J., Gajdhar A.U.R., Dowling M., Johnson S.B., Barie P.S., Winchell R.J. et al. A comprehensive review of topical hemostatic agents: the good, the bad, and the novel. J. Trauma Acute Care Surg. 2020; 88(1): e1-e21. https://dx.doi.org/10.1097/TA.0000000000002508
7. MacDonald M.H., Wang A.Y., Clymer J.W., Hutchinson R.W., Kocharian R. An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models. Med. Devices (Auckl). 2017; 10: 273-9. https://dx.doi.org/10.2147/MDER.S140663
8. Ishikura H., Nishiwaki T., Fujita S., Masuyama Y., Hatano M., Tanaka T. et al. Oxidized regenerated cellulose powder reduces perioperative bleeding and thigh swelling in total hip arthroplasty: a prospective interventional study. J. Orthop. Surg. Res. 2025; 20(1): 505. https://dx.doi.org/10.1186/s13018-025-05913-x
9. Yoon P.W., Kim H.J., Yoon J.Y., Moon J.K., Lee S. The efficacy of oxidised regenerated cellulose powder in reducing blood loss during primary total hip arthroplasty: a retrospective cohort study. J. Orthop. Surg. Res. 2025; 20(1): 368. https://dx.doi.org/10.1186/s13018-025-05782-4
10. Wakasa J., Iwakiri K., Ohta Y., Minoda Y., Kobayashi A., Nakamura H. Perioperative bleeding control in total hip arthroplasty: hemostatic powder vs. tranexamic acid-a prospective randomized controlled trial. Arch. Orthop. Trauma Surg. 2024; 144(8): 3797-805. https://dx.doi.org/10.1007/s00402-024-05475-3
11. Kaneko T., Hayakawa K., Miyazaki T. Clinical efficacy of oxidized regenerated cellulose powder in perioperative blood management in direct anterior total hip arthroplasty. SICOT J. 2025; 11: 36. https://dx.doi.org/10.1051/sicotj/2025036
12. Fagotti A., Costantini B., Fanfani F., Vizzielli G., Rossitto C., Lecca A. et al. Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience. Ann. Surg. Oncol. 2010; 17(9): 2452-8. https://dx.doi.org/10.1245/s10434-010-1059-3
13. Behbehani S., Tulandi T. Oxidized regenerated cellulose imitating pelvic abscess. Obstet. Gynecol. 2013; 121(2 Pt 2 Suppl 1): 447-9. https://dx.doi.org/10.1097/aog.0b013e318276ce3f
14. Tam T., Harkins G., Dykes T., Gockley A., Davies M. Oxidized regenerated cellulose resembling vaginal cuff abscess. JSLS. 2014; 18(2): 353-6. https://dx.doi.org/10.4293/108680813X13693422518597
15. Ng E.P., Tung K.L., Yip S.L., Tse M.S., Kwok T.K., Wong K.K. A prospective randomised controlled trial evaluating prophylactic Floseal, a gelatin and thrombin-based haemostatic matrix, in postoperative drain output and blood transfusion in transforaminal lumbar interbody fusion surgery. Eur. Spine J. 2023; 32(7): 2282-7. https://dx.doi.org/10.1007/s00586-023-07748-8
16. Luo P., Lai Q., Xu L., Chen Z., Guo R., Xie B. et al. Efficacy and safety evaluation of a novel hemostatic gelatin matrix for intraoperative hemostasis: a prospective, randomized controlled trial. Sci. Rep. 2024; 14(1): 27324. https://dx.doi.org/10.1038/s41598-024-77487-3
17. Ponce J., García-Tejedor A., Barahona M., Cappuccio S., Costantini B., Fedele C. et al. Effectiveness and safety of an absorbable modified polymer starch powder hemostat versus usual care in gynecology procedures: a prospective, multi-center, and randomized study. PLoS One. 2025; 20(9): e0331376. https://dx.doi.org/10.1371/journal.pone.0331376
18. Chen Y., Wu L., Li P., Hao X., Yang X., Xi G. et al. Polysaccharide based hemostatic strategy for ultrarapid hemostasis. Macromol. Biosci. 2020; 20(4): e1900370. https://dx.doi.org/10.1002/mabi.201900370
19. Kenny S., Gabra H., Hall N.J., Flageole H., Illie B., Barnett E. et al. A study of safety and effectiveness of Evicel fibrin sealant as an adjunctive hemostat in pediatric surgery. Eur. J. Pediatr. Surg. 2024; 34(6): 512-21. https://dx.doi.org/10.1055/s-0044-1785443
20. Ибрагимова У.Д., Козаченко И.Ф., Адамян Л.В. Овариальный резерв и методы хирургического гемостаза при доброкачественных опухолях яичников. Акушерство и гинекология. 2025; 8: 150-8.
21. Montera R., Ficarola F., Plotti F., Terranova C., De Cicco Nardone C., Guzzo F. et al. The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study. Arch. Gynecol. Obstet. 2023; 307(5): 1521-8. https://dx.doi.org/10.1007/s00404-023-06957-2
22. Zou C.Y., Han C., Xing F., Jiang Y.L., Xiong M., Li-Ling J. et al. Smart design in biopolymer-based hemostatic sponges: from hemostasis to multiple functions. Bioact. Mater. 2024; 45: 459-78. https://dx.doi.org/10.1016/j.bioactmat.2024.11.034
23. Липатов В.А., Бордунова М.А., Панов А.А., Денисов А.А. К вопросу классификации местных кровоостанавливающих средств. Innova. 2022; 4(29): 38-41.
24. Zou C.Y., Li Q.J., Hu J.J., Song Y.T., Zhang Q.Y., Nie R. et al. Design of biopolymer-based hemostatic material: Starting from molecular structures and forms. Mater. Today Bio. 2022; 17: 100468. https://dx.doi.org/10.1016/j.mtbio.2022.100468
25. Stark M., Wang A.Y., Corrigan B., Woldu H.G., Azizighannad S., Cipolla G. et al. Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations. Res. Pract. Thromb. Haemost. 2024; 9(1): 102668. https://dx.doi.org/10.1016/j.rpth.2024.102668
26. Raimondo D., Raffone A., Saccone G., Travaglino A., Degli Esposti E., Mastronardi M. et al. Cellulose absorbable barrier for prevention of de-novo adhesion formation at the time of laparoscopic myomectomy: a systematic review and meta-analysis of randomized controlled trials. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 245: 107-13. https://dx.doi.org/10.1016/j.ejogrb.2019.12.033
27. Martines G., Digennaro R., De Fazio M., Capuano P. Cyanoacrylate sealant compared to fibrin glue in staple line reinforcement during laparoscopic sleeve gastrectomy. Pilot prospective observational study. G. Chir. 2017; 38(1): 50-2. https://dx.doi.org/10.11138/gchir/2017.38.1.050
28. Chen Y.S., Loh E.W., Shen S.C., Su Y.H., Tam K.W. Efficacy of fibrin sealant in reducing complication risk after bariatric surgery: a systematic review and meta-analysis. Obes. Surg. 2021; 31(3): 1158-67. https://dx.doi.org/10.1007/s11695-020-05098-8
29. Uccelli M., Targa S., Cesana G.C., Oldani A., Ciccarese F., Giorgi R. et al. Use of fibrin glue in bariatric surgery: analysis of complications after laparoscopic sleeve gastrectomy on 450 consecutive patients. Updates Surg. 2021; 73(1): 305-11. https://dx.doi.org/10.1007/s13304-020-00865-9
30. Coskun H., Yardimci E. Effects and results of fibrin sealant use in 1000 laparoscopic sleeve gastrectomy cases. Surg. Endosc. 2017; 31(5): 2174-9. https://dx.doi.org/10.1007/s00464-016-5215-0
31. O'Hanlan K.A., Bassett P. Exploring adverse events and utilization of topical hemostatic agents in surgery. JSLS. 2022; 26(3): e2022.00033. https://dx.doi.org/10.4293/JSLS.2022.00033
32. Harris J.A., Uppal S., Kamdar N., Swenson C.W., Campbell D., Morgan D.M. A retrospective cohort study of hemostatic agent use during hysterectomy and risk of post-operative complications. Int. J. Gynaecol. Obstet. 2017; 136(2): 232-7. https://dx.doi.org/10.1002/ijgo.12037
33. Im D. Postoperative pelvic abscess risk in gynecologic surgery: a four-year single institution experience. Cureus. 2025; 17(10): e94383. https://dx.doi.org/10.7759/cureus.94383
34. Dolcetti V., Lori E., Fresilli D., Del Gaudio G., Di Bella C., Pacini P. et al. US evaluation of topical hemostatic agents in post-thyroidectomy. Cancers (Basel). 2023; 15(9): 2644. https://dx.doi.org/10.3390/cancers15092644
35. Rudy H.L., Shamamian P., Grande J., Wang F., Lu Y.H., Ricci J.A. Hemostatic agents do not significantly affect seroma formation in abdominal body contouring. Aesthetic Plast. Surg. 2024; 48(7): 1395-402. https://dx.doi.org/10.1007/s00266-023-03748-7
36. Al-Attar N., de Jonge E., Kocharian R., Ilie B., Barnett E., Berrevoet F. Safety and hemostatic effectiveness of SURGICEL® powder in mild and moderate intraoperative bleeding. Clin. Appl. Thromb. Hemost. 2023; 29: 10760296231190376. https://dx.doi.org/10.1177/10760296231190376
37. Howard M., Staples J.N., Nelamangala S., Kling C., Duska L.R. Evaluating the risk of post-operative abscess formation following use of hemostatic agents at time of hysterectomy. Gynecol. Oncol. Rep. 2022; 44: 101085. https://dx.doi.org/10.1016/j.gore.2022.101085

Поступила 23.12.2025

Принята в печать 26.12.2025